Has Bradley Berger received payments from drug or device companies?

Yes. Drug and device makers reported $3,245 in general payments to Bradley Berger across 229 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bradley Berger did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bradley Berger come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bradley Berger

Family Medicine · Clinton Twp, MINPI 1720077712

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,523 and has fallen 91.3% since, to $132 in 2023.

$3,245in general payments, 2019–2025

Across 229 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$751
GSK$315
Amgen$295
Astellas Pharma US Inc$254
Pfizer$243
Novo Nordisk$233
plus $1K from 15 others

What the payments were for

Food & beverage$3,14597%
Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	38	$751
GSK	26	$315
Amgen	25	$295
Astellas Pharma US Inc	11	$254
Pfizer	25	$243
Novo Nordisk	19	$233
Novartis	12	$175
Johnson & Johnson	10	$142
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	11	$141
Lilly USA, LLC	8	$99
E.r. Squibb & Sons, L.L.C.	6	$93
Takeda Pharmaceuticals U.S.A., Inc.	9	$92
Amarin Pharma, Inc.	6	$91
AstraZeneca	6	$70
Merck	5	$68
AbbVie	3	$42
Grifols USA, LLC	2	$36
Biohaven Pharmaceutical Holding Company Ltd.	2	$36
Sanofi-aventis U.S. LLC	2	$29
Radius Health, Inc.	2	$27
Arbor Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

JARDIANCE$121

How this compares

$3,245 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Other family medicine in Clinton Twp

Kurtis KieleszewskiClinton Twp$16K
Loren ChudlerSouthfield$1.3M
Paul BensonBerkley$779K
Matt RosenbergJackson$550K
Steve LasaterSaint Johns$291K
Mary DagenGrand Rapids$265K
Farhan BhattiLansing$230K
Jeffrey DeitchSterling Heights$197K
Sukhpreet SinghPlymouth$173K
James VoigtOak Park$140K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →